glp-1 obesity drug news today october 16 2025 ISPOR 2025: Exploring reasons for discontinuation The Obesity-Drug Revolution Is Stalling
Description
To date, however, no studies performed in humans are available
The most effective strategies are: Prioritising protein at each meal Aiming for regular resistance training (24 times per week if possible) Avoiding overly aggressive calorie restriction Ensuring overall diet quality despite reduced appetite These habits help signal the body to maintain muscle while losing fat
Your gut microbiome is home to millions of bacteria and other microorganisms living in your digestive system
Medicaid Spending on GLP-1 Drugs by State Data Source: IRIS by Real Chemistry | Image Credit: Real Chemistry Nationally, Medicaid spending on GLP-1s totaled $3.5 billion between November 2023 and October 2024, averaging $48 per Medicaid enrollee
Prior authorization policy
